Cardiac arrhythmia and thyroid dysfunction: A novel genetic link

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 11, 2010, Pages 1767-1770

  Purtell, Kerry ^a   Roepke, Torsten K ^b   Abbott, Geoffrey W ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Atrial fibrillation; Hyperthyroidism; Hypothyroidism; KCNE2; KCNQ1; Long QT Syndrome; MiRP1

Indexed keywords

POTASSIUM CHANNEL KCNQ1; POTASSIUM CHANNEL KCNQ2; THYROID HORMONE;

ANIMAL EXPERIMENT; BIOSYNTHESIS; GENE MUTATION; GENETIC LINKAGE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; MOUSE; NONHUMAN; SHORT SURVEY; THYROID DISEASE; THYROID FUNCTION;

ANIMALS; ARRHYTHMIAS, CARDIAC; ATRIAL FIBRILLATION; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; KCNQ1 POTASSIUM CHANNEL; LONG QT SYNDROME; POTASSIUM CHANNELS, VOLTAGE-GATED; THYROID DISEASES;

EID: 77957274957     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.07.013     Document Type: Short Survey

References (27)

1. Abbott G.W., Sesti F., Splawski I., Buck M.E., Lehmann M.H., Timothy K.W., et al. MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. Cell 1999, 97(2):175-187.
2. Bakiner O., Ertorer M.E., Haydardedeoglu F.E., Bozkirli E., Tutuncu N.B., Demirag N.G. Subclinical hypothyroidism is characterized by increased QT interval dispersion among women. Med Princ Pract 2008, 17(5):390-394.
3. Chen H., Kim L.A., Rajan S., Xu S., Goldstein S.A. Charybdotoxin binding in the I(Ks) pore demonstrates two MinK subunits in each channel complex. Neuron 2003, 40(1):15-23.
4. Chen Y.H., Xu S.J., Bendahhou S., Wang X.L., Wang Y., Xu W.Y., et al. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003, 299(5604):251-254.
5. Dohan O., De la Vieja A., Paroder V., Riedel C., Artani M., Reed M., et al. The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance. Endocr Rev 2003, 24(1):48-77.
6. Forfar J.C., Miller H.C., Toft A.D. Occult thyrotoxicosis: a correctable cause of " idiopathic" atrial fibrillation. Am J Cardiol 1979, 44(1):9-12.
7. Hak A.E., Pols H.A., Visser T.J., Drexhage H.A., Hofman A., Witteman J.C. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 2000, 132(4):270-278.
8. Hapon M.B., Simoncini M., Via G., Jahn G.A. Effect of hypothyroidism on hormone profiles in virgin, pregnant and lactating rats, and on lactation. Reproduction 2003, 126(3):371-382.
9. Heitzmann D., Grahammer F., von Hahn T., Schmitt-Graff A., Romeo E., Nitschke R., et al. Heteromeric KCNE2/KCNQ1 potassium channels in the luminal membrane of gastric parietal cells. J Physiol 2004, 561(Pt 2):547-557.
10. Hesketh J.C., Qi X., Li D., Levesque P., Nattel S. Cardiac function of KCNE2 subunits revealed by targeted deletion in mice. Am Heart Assoc Sci Sessions 2005, [session number AOP.16.2a (presentation number 278)].
11. Jiang M., Zhang M., Tang D.G., Clemo H.F., Liu J., Holwitt D., et al. KCNE2 protein is expressed in ventricles of different species, and changes in its expression contribute to electrical remodeling in diseased hearts. Circulation 2004, 109(14):1783-1788.
12. Kathiresan S., Voight B.F., Purcell S., Musunuru K., Ardissino D., Mannucci P.M., et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 2009, 41(3):334-341.
13. Keating M.T, Sanguinetti M.C. Molecular and cellular mechanisms of cardiac arrhythmias. Cell 2001, 104(4):569-580.
14. Klein I., Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001, 344(7):501-509.
15. Lafranchi S.F Newborn screening strategies for congenital hypothyroidism: an update. J Inherit Metab 2010, [Dis. epub ahead of print (March 2nd)].
16. Lee M.P., Ravenel J.D., Hu R.J., Lustig L.R., Tomaselli G., Berger R.D., et al. Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice. J Clin Invest 2000, 106(12):1447-1455.
17. Loh J.A., Wartofsky L., Jonklaas J., Burman K.D. The magnitude of increased levothyroxine requirements in hypothyroid pregnant women depends upon the etiology of the hypothyroidism. Thyroid 2009, 19(3):269-275.
18. McCrossan Z.A., Abbott G.W. The MinK-related peptides. Neuropharmacology 2004, 47(6):787-821.
19. Roepke T.K., Anantharam A., Kirchhoff P., Busque S.M., Young J.B., Geibel J.P., et al. The KCNE2 potassium channel ancillary subunit is essential for gastric acid secretion. J Biol Chem 2006, 281(33):23740-23747.
20. Roepke T.K., King E.C., Reyna-Neyra A., Paroder M., Purtell K., Koba W., et al. Kcne2 deletion uncovers its crucial role in thyroid hormone biosynthesis. Nat Med 2009, 15(10):1186-1194.
21. Roepke T.K., Kontogeorgis A., Ovanez C., Xu X., Young J.B., Purtell K., et al. Targeted deletion of kcne2 impairs ventricular repolarization via disruption of I(K,slow1) and I(to,f). FASEB J 2008, 22(10):3648-3660.
22. Schroeder B.C., Waldegger S., Fehr S., Bleich M., Warth R., Greger R., et al. A constitutively open potassium channel formed by KCNQ1 and KCNE3. Nature 2000, 403(6766):196-199.
23. Tinel N., Diochot S., Borsotto M., Lazdunski M., Barhanin J. KCNE2 confers background current characteristics to the cardiac KCNQ1 potassium channel. EMBO J 2000, 19(23):6326-6330.
24. Tribulova N., Knezl V., Shainberg A., Seki S., Soukup T. Thyroid hormones and cardiac arrhythmias. Vasc Pharmacol 2010, 52(3-4):102-112.
25. Wang Q., Curran M.E., Splawski I., Burn T.C., Millholland J.M., VanRaay T.J., et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996, 12(1):17-23.
26. Yang Y., Xia M., Jin Q., Bendahhou S., Shi J., Chen Y., et al. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet 2004, 75(5):899-905.
27. Zimmermann M.B., Jooste P.L., Pandav C.S. Iodine-deficiency disorders. Lancet 2008, 372(9645):1251-1262.